Polymorphisms in methylenetetrahydrofolate reductase and methotrexate sensitivity in childhood acute lymphoblastic leukemia

被引：37

作者：

Taub, JW

Matherly, LH

Ravindranath, Y

Kaspers, GJL

Rots, MG

van Zantwijk, CH

机构：

[1] Wayne State Univ, Childrens Hosp Michigan, Karmanos Canc Inst, Sch Med, Detroit, MI 48201 USA

[2] Vrije Univ Hosp Amsterdam, Amsterdam, Netherlands

来源：

LEUKEMIA | 2002年 / 16卷 / 04期

关键词：

D O I：

10.1038/sj.leu.2402428

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：764 / 765

页数：2

共 9 条

[1] Polymorphisms of methylenetetrahydrofolate reductase and other enzymes: Metabolic significance, risks and impact on folate requirement [J].

Bailey, LB ;

Gregory, JF .

JOURNAL OF NUTRITION, 1999, 129 (05) :919-922

[2] Increased frequency of expression of elevated dihydrofolate reductase in T-cell versus B-precursor acute lymphoblastic leukemia in children [J].

Matherly, LH ;

Taub, JW ;

Wong, SC ;

Simpson, PM ;

Ekizian, R ;

Buck, S ;

Williamson, M ;

Amylon, M ;

Pullen, J ;

Camitta, B ;

Ravindranath, Y .

BLOOD, 1997, 90 (02) :578-589

[3]

MATHERLY LH, 1995, BLOOD, V85, P500

[4] Molecular and cellular correlates of methotrexate response in childhood acute lymphoblastic leukemia [J].

Matherly, LH ;

Taub, JW .

LEUKEMIA & LYMPHOMA, 1999, 35 (1-2) :1-20

[5] Differential methotrexate resistance in childhood T- versus common/PreB-acute lymphoblastic leukemia can be measured by an in situ thymidylate synthase inhibition assay, but not by the MTT assay [J].

Rots, MG ;

Pieters, R ;

Kaspers, GJL ;

van Zantwijk, CH ;

Noordhuis, P ;

Mauritz, R ;

Veerman, AJP ;

Jansen, G ;

Peters, GJ .

BLOOD, 1999, 93 (03) :1067-1074

[6] Methotrexate resistance in relapsed childhood acute lymphoblastic leukaemia [J].

Rots, MG ;

Pieters, R ;

Peters, GJ ;

Noordhuis, P ;

Van Zantwijk, CH ;

Henze, G ;

Janka-Schaub, GE ;

Veerman, AJP ;

Jansen, G .

BRITISH JOURNAL OF HAEMATOLOGY, 2000, 109 (03) :629-634

[7] MTHFR gene polymorphism and severe toxicity during adjuvant treatment of early breast cancer with cyclophosphamide, methotrexate, and fluorouracil (CMF) [J].

Toffoli, G ;

Veronesi, A ;

Boiocchi, M ;

Crivellari, D .

ANNALS OF ONCOLOGY, 2000, 11 (03) :373-374

[8] Pharmacogenetics of methotrexate: toxicity among marrow transplantation patients varies with the methylenetetrahydrofolate reductase C677T polymorphism [J].

Ulrich, CM ;

Yasui, Y ;

Storb, R ;

Schubert, MM ;

Wagner, JL ;

Bigler, J ;

Ariail, KS ;

Keener, CL ;

Li, S ;

Liu, H ;

Farin, FM ;

Potter, JD .

BLOOD, 2001, 98 (01) :231-234

[9]

Zhang L, 1998, CLIN CANCER RES, V4, P2169

← 1 →